Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
380 participants
OBSERVATIONAL
2007-05-31
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community-acquired Pneumonia in Buskerud County in Norway
NCT01563315
Clinical Characteristics of Acutely Hospitalized Adults With Community-acquired- Pneumonia
NCT04681963
Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.
NCT04106037
Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway
NCT04381247
Etiology of Community Acquired Pneumonia
NCT00471757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore 500 patients with community acquired pneumonia admitted to Telemark hospital and Ostfold hospital in Norway will be tested by urin antigen test for the detection of Legionella pneumophila serogroup 1 and Streptococcus pneumoniae. We will also perform routine bacterial culture of sputum and culture on medium for isolation of Legionella species. A throat swab from the patients will be tested for Mycoplasma pneumoniae, Chlamydophila pneumoniae and Bordetella pertussis using PCR-techniques. Legionella-serology will also be performed. In addition all the included patients are invited to fill in a questionnaire in order to look for risk factors for developing community acquired pneumonia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Serious psychiatric illness
* Mentally retarded
* Hospitalized last 14 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sykehuset Ostfold
OTHER
Sykehuset Telemark
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sykehuset Telemark HF, Norway
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Halfrid Waage, dr.med
Role: STUDY_CHAIR
Telemark Hospital, 3710 Skien, Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sykehuset Telemark
Skien, Telemark, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSD: 16388
Identifier Type: -
Identifier Source: secondary_id
REK: S-05393
Identifier Type: -
Identifier Source: secondary_id
STHF 5690.10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.